First feline prostatic phyllodes tumor described in case report
Bottom line
A newly published case report in Veterinary Radiology & Ultrasound describes what the authors say is the first reported phyllodes tumor of the prostate in a cat, expanding the short list of recognized feline prostatic neoplasms. In the case, a 12-year-old neutered male domestic shorthair presented with lower urinary tract and gastrointestinal signs, and CT identified an intrapelvic mass that was later confirmed histopathologically as a prostatic phyllodes tumor. The cat underwent debulking surgery with temporary clinical improvement, but follow-up imaging showed local progression and possible metastasis. The report adds a novel differential diagnosis for older male cats with pelvic masses, dysuria, dyschezia, or both. (ncbi.nlm.nih.gov)
Why it matters: Prostatic disease is considered rare in cats, and the veterinary literature has historically been dominated by carcinoma case reports and small reviews rather than a broad tumor spectrum. A 2022 review noted that very little is known about feline prostatic disease because of its uncommon occurrence, while earlier reports described most feline prostatic tumors as carcinomas in older male cats. Against that backdrop, this case is useful for radiologists, surgeons, internists, and pathologists because it suggests that a heterogeneous intrapelvic or periprostatic mass in a cat may not fit the usual carcinoma pattern, and that cross-sectional imaging plus histopathology remain critical for diagnosis and staging. (pubmed.ncbi.nlm.nih.gov)
What to watch: Whether additional case reports clarify the imaging hallmarks, biologic behavior, and metastatic risk of feline prostatic phyllodes tumors, and whether this entity is incorporated into future reviews of feline prostate pathology. (pubmed.ncbi.nlm.nih.gov)
Key facts
- Publication
- Veterinary Radiology & Ultrasound
- Finding
- First reported phyllodes tumor of the prostate in a cat
- Patient
- 12-year-old neutered male domestic shorthair cat
- Presenting signs
- Lower urinary tract and gastrointestinal signs
- Imaging
- CT identified an intrapelvic mass
- Diagnosis
- Histopathology confirmed a prostatic phyllodes tumor
- Treatment
- Debulking surgery
- Outcome
- Temporary clinical improvement, then local progression and possible metastasis
- Clinical takeaway
- Consider prostatic origin in older male cats with pelvic masses, dysuria, or dyschezia
A case report in Veterinary Radiology & Ultrasound has identified what appears to be the first documented phyllodes tumor of the prostate in a cat, giving clinicians a new, if very rare, diagnosis to consider when working up older male cats with obstructive urinary or pelvic signs. According to the abstract, the patient was a 12-year-old neutered male domestic shorthair with lower urinary tract and gastrointestinal symptoms; CT revealed an intrapelvic mass, and histopathology confirmed a prostatic phyllodes tumor. After debulking surgery, the cat improved temporarily, but later imaging showed local progression and possible metastatic spread. (ncbi.nlm.nih.gov)
That matters because feline prostatic disease remains an exceptionally thin evidence base. A 2022 review of canine and feline prostate pathology said that, in cats, the rare occurrence of prostate disease means there is still limited knowledge about pathogenesis, diagnosis, treatment, and prognosis. Earlier feline case literature has centered largely on carcinoma, including reports of prostatic carcinoma causing urethral obstruction and obstipation, and a separate case of surgically treated prostatic biphasic tumor in a cat. In other words, this new report doesn't just add one more case, it broadens the known pathology of the feline prostate. (pubmed.ncbi.nlm.nih.gov)
The source abstract points to a clinically familiar presentation with an unfamiliar diagnosis: mixed lower urinary tract and gastrointestinal signs caused by a pelvic mass effect. That overlap tracks with prior feline prostatic and periurethral tumor reports, where constipation, dyschezia, urethral obstruction, and hematuria have all appeared in the clinical picture. For clinicians, the take-home is less about memorizing a rare tumor name and more about recognizing that pelvic masses in older neutered male cats can compress both urinary and gastrointestinal structures, making advanced imaging especially valuable in defining origin, extent, and surgical options. (ncbi.nlm.nih.gov)
There is also useful context from human medicine, where phyllodes tumor of the prostate is itself rare but recognized as a biphasic epithelial-stromal neoplasm that can recur locally and, in some cases, metastasize. Published human case reports describe obstructive lower urinary tract signs, recurrent disease after incomplete resection, and lung metastases even in tumors classified as low grade. While cross-species comparisons should be made cautiously, the feline case's reported local progression and possible metastasis are directionally consistent with the variable and sometimes aggressive behavior described in people. That makes margin status, surveillance imaging, and realistic prognosis discussions especially relevant if similar feline cases emerge. (pubmed.ncbi.nlm.nih.gov)
I didn't find a separate press release or formal industry statement tied to this publication, which isn't unusual for a single veterinary case report. I also didn't find attributable expert commentary specific to this paper. The strongest outside context came from reviews and prior feline case reports showing how uncommon prostatic tumors are in cats, and how limited the profession's pattern recognition still is for these cases. (pubmed.ncbi.nlm.nih.gov)
Why it matters: For veterinary professionals, this report is a reminder that rare pathology can sit behind common referral complaints. In practice, cats with stranguria, dyschezia, constipation, pelvic canal narrowing, or recurrent lower urinary signs may be worked up primarily for urethral disease, colonic disease, or more familiar neoplasia. This case argues for keeping prostatic origin on the list, even in cats, and for using imaging and tissue diagnosis to distinguish among carcinoma, biphasic tumors, inflammatory disease, cystic lesions, and other pelvic masses. It also underscores the limits of extrapolating prognosis from the small number of feline prostate cases currently in the literature. (ncbi.nlm.nih.gov)
What to watch: The next meaningful development will be whether more centers report comparable cases, including ultrasound or CT patterns, immunohistochemical findings, treatment choices, and follow-up intervals. If additional reports appear, they could help determine whether feline prostatic phyllodes tumor behaves more like an isolated oddity, a newly recognized but underdiagnosed entity, or a tumor type with a reproducible risk of recurrence and metastasis that should shape surgical planning and monitoring recommendations. (ncbi.nlm.nih.gov)